Skip to main content
. 2023 Jan 17;13:1054216. doi: 10.3389/fendo.2022.1054216

Table 2.

Expression and application of piRNAs in urological tumors.

piRNA types Functions \ possible clinical applications expression References
Renal carcinoma
 piR-32051 Prognostic marker Up regulation (28)
 piR-39894 Prognostic marker Up regulation
 piR-43607 Prognostic marker Up regulation
 piR-30924 Prognostic marker Up regulation (90, 91)
 piR-38756 Prognostic marker Up regulation
 piR-57125 Inhibit cancer cell proliferation, invasion, and migration, and can be used as a diagnostic tool and a therapeutic target Down regulation
 piR-34536 Prognostic marker Down regulation (92)
 piR-51810 Prognostic marker Down regulation
 piR-823 Diagnostic tool Down regulation (93)
 piR-823(urine) Diagnostic tool Up regulation
 piR-31115 Promote cancer cell proliferation, invasion, and migration, and can be used as a diagnostic tool and a therapeutic target Up regulation (94)
Bladder cancer
 piRABC(piRNADQ594040、piR-60152) Inhibit cancer cell proliferation, invasion, and migration, and promote apoptosis, and can be used as a diagnostic tool and a therapeutic target Down regulation (95)
 piR-5936(plasma exosomes) Diagnostic tool Up regulation (29)
Prostate cancer
 piR-651 Related to hormone therapy for cancer Up regulation (96)
 piR-823 Related to hormone therapy for cancer Up regulation
 piR-001773 Promote cancer cell proliferation, invasion, and migration, and can be used as a diagnostic tool and a therapeutic target Up regulation (30)
 piR-017184 Promote cancer cell proliferation, invasion, and migration, and can be used as a diagnostic tool and a therapeutic target Up regulation
 piR-31470 Promote cancer cell proliferation, invasion, and migration, and can be used as a diagnostic tool and a therapeutic target Up regulation (97)
Testicular cancer
 PIWI/piRNA The loss of this pathway is beneficial to the proliferation, invasion, and migration of cancer cells Defect (31, 98, 99)

PubMed and Web of Science were used for searching the articles related to urological tumors and piRNA in the past 10 years.